We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Hep C

News List

Nurses Can Help Manage Drug Interactions in HIV/Hep C Treatment drugs
January 02, 2020
Drug interactions between antiretroviral therapy (ART) and direct-acting antivirals (DAAs) pose a clinical challenge in patients with HIV/hepatitis C virus (HCV) coinfection ...
Guideline Updated for Prevention, Management of Hep C in CKD drugs
September 24, 2019
In a synopsis of the 2018 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline, published online in the Annals of Internal Medicine, updated recommendations are presented for the prevention...
FDA Reports Rare Cases of Liver Injury, Failure With Hep C Therapies drugs
August 30, 2019
The U.S. Food and Drug Administration has received reports of rare cases of worsening liver function or liver failure in patients with chronic hepatitis C virus (HCV) who had moderate-to-severe liver ...
AbbVie’s pan-genotypic hep C therapy cleared in the US pharmatimes
August 07, 2017
AbbVie’s hepatitis C therapy Mavyret has picked up an approval in the US just days after having been green lighted by regulators in Europe.